Weight Loss Plateaus Are Normal and Seen in Every Major GLP-1/GIP Study The Standard Weight-Loss Curve Clinical trials consistently show that weight loss with GLP-1 and GLP-1/GIP medications follows a predictable pattern: Rapid weight loss early Gradual slowing over time A plateau phase where weight stabilizes This pattern has been observed across: Semaglutide trials ( STEP program ) Tirzepatide trials ( SURMOUNT-1 , SURMOUNT-4 ) Long-term cardiovascular outcomes studies ( SELECT ) In these studies, most participants lost weight more rapidly during the first several months, then experienced a gradual slowing and reached their average maximum weight loss around 918 months , after which weight tended to stabilize rather than continue to drop indefinitely
Use whey, casein, or plant-based complete proteins as your foundation and add collagen as a supplementary source if desired
Understanding the correct dosage, timing, and administration of Ozempic may help ensure results while minimizing potential side effects
Two years off
There is currently no requirement for ACA plans to cover weight loss medications, but a growing number of plans including employer-sponsored and self-funded plans do cover medications like Zepbound and Wegovy
Understanding this difference is critical for anyone switching from a brand-name product to a compounded formulation